ALS patients had significantly higher plasma NFL concentrations than patients with other MNDs (p < 0.05), patients with neuropathies & myelopathies (p < 0.01), patients with myopathies (p < 0.01) and controls with no neurological disorders (p < 0.01) (Fig. 2E). This evidence concerns the gene NEFL and Myelopathy.